Trials / Completed
CompletedNCT05785429
The Effect of Colchicine on Food-related Effort-based Decision Making in Brain and Behaviour in Overweight and Obesity
The Effect of Colchicine on Food-related Effort-based Decision Making in Brain and Behaviour in Overweight and Obesity: the FLAIR-i Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Donders Centre for Cognitive Neuroimaging · Academic / Other
- Sex
- Female
- Age
- 18 Years – 59 Years
- Healthy volunteers
- Accepted
Summary
The main objective of the FLAIR-i study is to study the causal role of inflammation in affecting effort-based decision making in brain and behaviour in overweight and obesity, by comparing the effect of the anti-inflammatory agent colchicine vs. placebo.
Detailed description
Obesity is a major health problem worldwide and is characterized by increases in low-grade, systemic inflammation. Outside the field of obesity, increases in inflammation have been related to loss of motivation and effortful behaviour, which can be objectively measured with effort-based decision making in brain and behaviour. Here, the investigators hypothesise that low-grade inflammation is causing altered striatal brain responses and effortless 'fast food' choices in overweight and obesity. The objective of this study is to study the causal role of inflammation in affecting effort-based decision making in brain and behaviour in overweight and obese participants, by comparing the effect of the anti-inflammatory agent colchicine vs. placebo. In addition, it will be investigated whether this primary objective translates to more ecologically valid measures/settings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Colchicine 0.5 MG | Participant in the intervention group receive one tablet of 0.5mg colchicine per day for 12 weeks. |
| DRUG | Placebo | Participants in the intervention group receive one tablet of placebo per day for 12 weeks. |
Timeline
- Start date
- 2022-08-02
- Primary completion
- 2025-01-20
- Completion
- 2025-01-20
- First posted
- 2023-03-27
- Last updated
- 2025-09-02
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05785429. Inclusion in this directory is not an endorsement.